Fernando López‐Ríos

机构：Universidad Complutense de Madrid, Instituto de Salud Carlos III, Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre, Centro de Investigación Biomédica en Red de Cáncer · ORCID：0000-0001-6813-0395

发表论文 369 篇 · 总被引 12154 次 · h-index 57

代表论文

• Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries (2024 · The Lancet Regional Health - Europe · 被引 52)
• ESMO basic requirements for AI-based biomarkers in oncology (EBAI) (2025 · Annals of Oncology · 被引 41)
• Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee (2024 · Journal of Thoracic Oncology · 被引 41)
• Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation (2024 · Archives of Pathology & Laboratory Medicine · 被引 38)
• NTRK gene fusion testing and management in lung cancer (2024 · Cancer Treatment Reviews · 被引 22)
• Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists (2023 · Histopathology · 被引 22)